Product Program year 2025 Source: CMS Open Payments

SIR-Spheres Microspheres

Device Interventional Oncology

Open in the dashboard

General payments

$14,693,786

29,035 payments

Research payments

$7,238,414

795 payments

Through program year 2025, $14,693,786 in general payments and $7,238,414 in research payments were reported against SIR-Spheres Microspheres (Interventional Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $2,088,531 3,830
2025 Research $895,282 83
2024 General $2,287,852 4,496
2024 Research $1,722,853 166
2023 General $1,790,428 3,752
2023 Research $1,961,527 114
2022 General $1,707,290 3,783
2022 Research $1,309,095 119
2021 General $1,843,703 2,784
2021 Research $1,171,997 307
2020 General $1,978,534 3,736
2020 Research $172,660 5
2019 General $2,997,449 6,654
2019 Research $5,000 1

Breakdown

Who paid General payments · program years 2019–2025
  1. Sirtex Medical Inc $14,693,786 29,035 payments
Top recipients General payments · program year 2025
  1. Ripal Gandhi Vascular & Interventional Radiology · Miami, FL $269,010 13% · 322 payments
  2. Nima Kokabi Vascular & Interventional Radiology · Atlanta, GA $212,702 10% · 138 payments
  3. Edward Lee Vascular & Interventional Radiology · Los Angeles, CA $206,594 10% · 84 payments
  4. Suvranu Ganguli Vascular & Interventional Radiology · Boston, MA $108,337 5% · 104 payments
  5. Riad Salem Vascular & Interventional Radiology · Chicago, IL $103,909 5% · 12 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular & Interventional Radiology Radiology $1,764,453 84% · 586 practitioners
  2. Diagnostic Radiology Radiology $164,363 8% · 299 practitioners
  3. Medical Oncology Internal Medicine $42,628 2% · 20 practitioners
  4. Surgery $24,718 1% · 19 practitioners
  5. Hematology & Oncology Internal Medicine $16,237 <1% · 80 practitioners

The top 5 of 56 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $357,616 17% · 85 recipients
  2. California $353,223 17% · 146 recipients
  3. Georgia $211,849 10% · 21 recipients
  4. Texas $157,309 8% · 228 recipients
  5. Massachusetts $123,531 6% · 21 recipients

The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

29,035 general · 795 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record